• Mashup Score: 3
    What If Costco Designed the Prescription Drugs Sales Model? - HealthPopuli.com - 2 year(s) ago

    The good news about prescription drugs, in the context of medical spending in the U.S., is that 9 in 10 medicines prescribed are generics. They comprise only 3% of all U.S. healthcare spending.           But there’s bad news about prescription drugs in the context of medical spending in America. U.S. Consumers Overpay for Generic Drugs, a new paper from the Leonard Schaeffer Center for Health…

    Source: HealthPopuli.com
    Categories: Healthcare Professionals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of healthythinker
      healthythinker

      What if @Costco designed the US #prescriptiondrugs pricing/selling model? https://t.co/y2XOLbLDp4 @USC @SchaefferCenter team analyzed #Medicare data finding Americans overpay for #prescriptiondrugs vs Costco pricing for 184 generics #healtheconomics #retailhealth #drugcosts https://t.co/qMTZVAZy7V

  • Mashup Score: 5
    Pondering Prescription Drugs: Pricing Rx and Going Direct-to-Consumer - HealthPopuli.com - 3 year(s) ago

    There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs. With the price of medicines in politicians’ and health citizens’ cross-hairs, the pharmaceutical and biotech industries have responded in many ways to the Rx pricing critiques from consumers (via, for example, Consumer Reports/Consumers Union and…

    Source: HealthPopuli.com
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JohnNosta
      JohnNosta

      In a word, UNSUSTAINABLE. https://t.co/6E36JwcoZM by @healthythinker. #medicine #pharma #drugcosts #digitalhealth https://t.co/Ezw64TBSoK

  • Mashup Score: 0
    Rogue drug maker first inflates the price of lomustine, then says No to Medicare coverage - The Cancer Letter - 3 year(s) ago

    Over the past year, we have witnessed the awesome power of American pharmaceutical and biotechnology companies.  With unprecedented speed, at least three different U.S. companies created vaccines that will significantly curtail the spread of a deadly global pandemic.  Yet, while some headlines nearly deified these pharma giants, a darker story about the power of American […]

    Source: The Cancer Letter
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of fumikochino
      fumikochino

      "NextSource’s actions shine a light on the stranglehold pharmaceutical companies have on patients, providers & our federal government, particularly its capability to impose reasonable limits on drug pricing." @TheCancerLetter #healthpolicy #drugcosts https://t.co/sazWZxgh7k

    • Profile photo of fumikochino
      fumikochino

      💸 @OncoAlert: "Since taking over manufacturing rights, NextSource has become the single-source manufacturer of lomustine in the US... Today, NextSource’s list price is ~1,900% higher than it was just 8 years ago" #pricegauging #btsm #financialToxicity https://t.co/sazWZxgh7k https://t.co/THlwouKqhY

  • Mashup Score: 0
    Too Much Money for the Medicine - 3 year(s) ago

    Newer cancer therapies easily cost upward of $100,000. Why so much? Who sets the prices and what can patients do if they can’t afford them?

    Source: Cure Today
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of andrewschorr
      andrewschorr

      I am grateful for my meds but mindful of the high costs. See this article including me and other patients/experts: https://t.co/6OhxiR2H4D. #drugcosts #pharmaceuticals #patientpower #healtheconomics

Load More